Advertisement
Screener

CONSTELLIUM SE (CSTM) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

CONSTELLIUM SE Research and Development Expense

CONSTELLIUM SE (CSTM) reported Research and Development Expense of $13.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-29

  • CONSTELLIUM SE research and development expense for the quarter ending 2026-03-31 was $13.00M, a 0.00% change year-over-year.
  • CONSTELLIUM SE research and development expense for the quarter ending 2025-12-31 was $14.00M, a 40.00% increase year-over-year.
  • CONSTELLIUM SE research and development expense for the quarter ending 2025-09-30 was $12.00M, a 9.09% increase year-over-year.
  • CONSTELLIUM SE research and development expense for the quarter ending 2025-06-30 was $12.00M, a 7.69% decline year-over-year.
  • CONSTELLIUM SE research and development expense for fiscal 2025 was $51.00M, a 4.08% increase from fiscal 2024.
  • CONSTELLIUM SE research and development expense for fiscal 2024 was $49.00M, a 5.77% decline from fiscal 2023.
  • CONSTELLIUM SE research and development expense for fiscal 2023 was $52.00M, a 13.04% increase from fiscal 2022.
  • CONSTELLIUM SE research and development expense for fiscal 2022 was $46.00M.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2026-03-31$13.00M
10-Q · filed 2026-04-29
$27.00M
derived: sum of 2 quarters · filed 2026-04-29
$39.00M
derived: sum of 3 quarters · filed 2026-04-29
$51.00M
derived: sum of 4 quarters · filed 2026-04-29
2025-12-31$14.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$26.00M
derived: sum of 2 quarters · filed 2026-02-25
$38.00M
derived: sum of 3 quarters · filed 2026-02-25
$51.00M
10-K · filed 2026-02-25
2025-09-30$12.00M
10-Q · filed 2025-10-29
$24.00M
derived: sum of 2 quarters · filed 2025-10-29
$37.00M
10-Q · filed 2025-10-29
$47.00M
derived: sum of 4 quarters · filed 2026-04-29
2025-06-30$12.00M
10-Q · filed 2025-07-31
$25.00M
10-Q · filed 2025-07-31
$35.00M
derived: sum of 3 quarters · filed 2026-04-29
$46.00M
derived: sum of 4 quarters · filed 2026-04-29
2025-03-31$13.00M
10-Q · filed 2026-04-29
$23.00M
derived: sum of 2 quarters · filed 2026-04-29
$34.00M
derived: sum of 3 quarters · filed 2026-04-29
$47.00M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31$10.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$21.00M
derived: sum of 2 quarters · filed 2026-02-25
$34.00M
derived: sum of 3 quarters · filed 2026-02-25
$49.00M
10-K · filed 2026-02-25
2024-09-30$11.00M
10-Q · filed 2025-10-29
$24.00M
derived: sum of 2 quarters · filed 2025-10-29
$39.00M
10-Q · filed 2025-10-29
2024-06-30$13.00M
10-Q · filed 2025-07-31
$28.00M
10-Q · filed 2025-07-31
2024-03-31$15.00M
10-Q · filed 2025-04-30
2023-12-31$52.00M
10-K · filed 2026-02-25
2022-12-31$46.00M
10-K · filed 2025-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aqua Metals, Inc. (AQMS)United States$0.009B-0.64